Literature DB >> 17936527

Pharmacokinetics and metabolism of lithospermic acid by LC/MS/MS in rats.

Li Wang1, Qiang Zhang, Xiaochuan Li, Youli Lu, Zhimou Xue, Lijiang Xuan, Yiping Wang.   

Abstract

The pharmacokinetics and metabolism of lithospermic acid (LA), a component isolated from Salvia miltiorrhiza, and its two O-methylated metabolites (3'-monomethyl- and 3',3''-dimethyl-lithospermic acid), were analyzed by a rapid and specific isocratic liquid chromatography-tandem mass spectrometry (LC/MS/MS) method. Rat serum samples collected after intravenous and oral administration were analyzed for obtaining pharmacokinetic data of LA. Two O-methylated metabolites, namely one 3'-monomethyl- and one 3',3''-dimethyl-lithospermic acid were detected in rat serum and bile samples after intravenous and oral administration of LA, respectively. An oral bioavailability of 1.15% was found, with the AUC(0-t) values of 301.89 and 3.46mgh/L for intravenous and oral administration, respectively. The total recovery from bile was 75.36% (0.46% for LA, 17.23% for M1, and 57.67% for M2) after intravenous administration, and 4.26% (0.00% for LA, 0.10% for M1, and 4.16% for M2) after oral administration. These results indicate that methylation is the main metabolic pathway of LA, and that LA is excreted into rat bile and finally into feces.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936527     DOI: 10.1016/j.ijpharm.2007.09.001

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

1.  Pharmacokinetics, tissue distribution, and metabolites of a polyvinylpyrrolidone-coated norcantharidin chitosan nanoparticle formulation in rats and mice, using LC-MS/MS.

Authors:  Xin-Yuan Ding; Cheng-Jiao Hong; Yang Liu; Zong-Lin Gu; Kong-Lang Xing; Ai-Jun Zhu; Wei-Liang Chen; Lin-Seng Shi; Xue-Nong Zhang; Qiang Zhang
Journal:  Int J Nanomedicine       Date:  2012-04-02

Review 2.  Salvia miltiorrhiza Roots against Cardiovascular Disease: Consideration of Herb-Drug Interactions.

Authors:  Feng Chen; Li Li; Dan-Dan Tian
Journal:  Biomed Res Int       Date:  2017-04-03       Impact factor: 3.411

Review 3.  Salvia miltiorrhiza Bge. (Danshen) in the Treating Non-alcoholic Fatty Liver Disease Based on the Regulator of Metabolic Targets.

Authors:  Jie Liu; Yun Shi; Daiyin Peng; Lei Wang; Nianjun Yu; Guokai Wang; Weidong Chen
Journal:  Front Cardiovasc Med       Date:  2022-04-22

4.  Investigating the Mechanisms of Action of Depside Salt from Salvia miltiorrhiza Using Bioinformatic Analysis.

Authors:  Hua Li; Hongying Liu
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-19       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.